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integrative approach to artificial cells
Ahanjit Bhattacharya,† Roberto J. Brea † and Neal K. Devaraj *
The assembly of artificial cells provides a novel strategy to reconstruct life's functions and shed light on how
life emerged on Earth and possibly elsewhere. A major challenge to the development of artificial cells is the
establishment of simple methodologies to mimic native membrane generation. An ambitious strategy is the
bottom-up approach, which aims to systematically control the assembly of highly ordered membrane
architectures with defined functionality. This perspective will cover recent advances and the current
state-of-the-art of minimal lipid architectures that can faithfully reconstruct the structure and function
of living cells. Specifically, we will overview work related to the de novo formation and growth of
biomimetic membranes. These studies give us a deeper understanding of the nature of living systems
and bring new insights into the origin of cellular life.1. Introduction
Self-assembly is central to the very organization of life.1 It is
believed that self-assembly played a key role in the origin of life
by organizing building blocks for more complex structures.
Non-covalent interactions like hydrogen bonding, van der
Waals forces, and dipolar interactions play major role in this
process.2 A wide variety of building blocks ranging from simple
amphiphiles, polymers, crystals, and nanostructures are
capable of self-assembly.3 Every living cell is bounded by
a highly dynamic and semi-permeable cell membrane, which is, University of California, San Diego, La
sd.edu
is work.
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related to the origin of life.mainly composed of amphiphilic phospholipids. In aqueous
solutions, phospholipids spontaneously self-assemble into
membrane-bound structures called vesicles. This process is
largely driven by hydrophobic interactions between the non-
polar fatty acyl chains of the phospholipid molecules, which
segregates them from the aqueous bulk solution. Phospholipids
are quite complex amphiphiles and may not have evolved
without a sophisticated biochemical machinery.4 Previous
studies have suggested that the earliest membranes were
composed of simple single-chain amphiphiles like fatty acids
and fatty alcohols derived from geochemical processes and
extraterrestrial sources (meteorites and comets).5 Such vesicles
have been shown to be capable of harboring prebiotically
plausible molecules and sustaining a few simple biochemical
reactions.6 However, an increase in the complexity ofRoberto J. Brea received his PhD
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Fig. 1 De novo formation of phospholipids based on the biosynthetic
pathway, which involves multiple membrane-bound enzyme-cata-
lyzed steps, substrates and cofactors [GPAAT: glycerol-3-phosphate:
acyl-CoA acyltransferase, LPAAT: lysophosphatidic acid acyltransfer-
ase, G3P: glycerol 3-phosphate, CoA: coenzyme A, FACoA: fatty acyl
coenzyme A, LPA: lysophosphatidic acid, PA: phosphatidic acid, PL:
phospholipid].
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View Article Onlinemembrane-forming molecules must have been necessary to the
early evolution of life. It has been hypothesized that the
inclusion of phospholipids provided a competitive edge to
protocells containing them.7 Therefore, it is important to
understand the plausible pathways which led to earliest
emergence of phospholipids and other complex amphiphiles.
Phospholipid membranes have been extensively utilized for
studying biological membranes, as drug delivery vehicles,
monitoring drug–receptor interactions, and as components of
microreactors.8–10 Physicochemical studies on the properties of
phospholipid membranes also comprise a rich literature.11
More recently, there has been a signicant interest in using
phospholipid vesicular structures as model systems for bottom-
up construction of synthetic life.12,13 We envision that this goal
can be successfully accomplished through the use of an inte-
grative approach based on increasing complexity in the
following hierarchical manner: (1) exploration of facile che-
moselective reactions for generation of phospholipids and
other membrane forming molecules, (2) growth and division of
vesicles driven by a catalytic process, (3) attributing function-
alities to the articial cell membranes to mimic biological
processes, (4) use of vesicles as microreactors for gene expres-
sion and simple biochemical reactions, (5) integrating growth,
division and metabolic events to genetic circuits, and (6)
demonstration of Darwinian evolution. In this perspective, we
will discuss the accomplishments in the area of vesicle-based
synthetic cells, with a special emphasis on de novo construc-
tion of biomimetic membranes.2. Self-assembly driven by simple
chemical reactions
2.1. De novomembrane formation: inspiration from biology
In nature, membrane-forming lipids are synthesized in
multiple enzyme-catalyzed steps and involves several cofactors
(Fig. 1).14 Over the last years, there has been considerable effort
in reconstituting these biochemical reactions in liposomes,
albeit with varying degrees of success.15 The key enzymes forNeal K. Devaraj received his PhD
in Chemistry (2007) from the
Stanford University under the
guidance of Prof. James P. Coll-
man and Prof. Christopher
Chidsey. Aer performing post-
doctoral studies in the group of
Prof. Ralph Weissleder at Har-
vard University, he joined the
Faculty of Chemistry and
Biochemistry of the University of
California, San Diego (USA),
where he leads an interdisci-
plinary group focused on developing novel reactions for addressing
questions in bottom-up synthetic biology and molecular imaging.
He is the recipient of the 2016 National Fresenius Award and the
2017 ACS Award in Pure Chemistry.
This journal is © The Royal Society of Chemistry 2017lipid synthesis pathways are membrane-bound proteins,14 and
hence difficult to reconstitute in functional form. The reliance
on integral membrane proteins implies that new biological
membranes cannot be synthesized without pre-existing
membranes. For the bottom-up design of an articial cell,
a fundamentally different strategy is desirable. To eliminate the
necessity for pre-existing membranes, the reactive precursors
should themselves be non-membrane forming and can react
among themselves in a chemoselective fashion to form
membrane-forming materials. We refer to this strategy as de
novo membrane formation. Inspiration for this strategy was
drawn from the Land's Cycle – a process which takes place in
biological membranes for phospholipid remodeling.16 In this
cycle, non-membrane forming single-chain amphiphiles–lyso-
phospholipids and fatty acyl-CoA thioesters – are coupled
together by the enzyme lysophospholipid acyltransferase
(LPLAT). In early seminal work, Deamer and co-workers showed
that membranes can be reconstituted from water-soluble
precursors by utilizing the LPLAT activity of solubilized liver
microsomal membranes.17,18 However, the system was not well-
dened and not suitable for using as such for bottom-up
membrane assembly. It will be more desirable to utilize
simple, robust and high-yielding reactions for this purpose. In
the following sections, we will discuss the applications of bio-
orthogonal and chemoselective coupling reactions for de novo
membrane assembly.2.2. Click chemistry-based approaches
Given the relevance of mimicking biological systems, several
groups have recently explored methodologies for the de novo
formation of synthetic lipid membranes from reactiveChem. Sci., 2017, 8, 7912–7922 | 7913
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View Article Onlineprecursors. The rst example based on a bioorthogonal
approach19 utilized the copper(I) catalyzed azide–alkyne cyclo-
addition (CuAAC)20–22 reaction to drive the assembly of
membranes (Fig. 2).19 This system employs a biomimetic
coupling reaction to join an alkyne-functionalized lysophos-
pholipid and an alkyl azide in presence of a copper catalyst,
which generates an abiological triazole-linked phospholipid. As
expected, neither the alkyne nor azide precursors formed
membranes in aqueous solution. However, the triazole-
containing phospholipid product, when hydrated, readily
formed membrane vesicles. In situmembrane formation occurs
spontaneously and does not require pre-existing membranes to
house catalysts or precursors. Bioorthogonal click chemistry
reactions take place at the interface of insoluble alkyl azide
emulsion droplets and the monolayers of alkyne lysolipid that
presumably coat the droplets. Steady-state uorescence anisot-
ropy measurements showed that the triazole phospholipid
membranes closely resemble their natural counterparts in
uidity properties. Overall, the strategy is biomimetic in that itFig. 2 Biomimetic formation of phospholipid membranes driven by
a copper(I) catalyzed azide–alkyne cycloaddition (CuAAC) reaction.
Reactive alkyl azide oil droplets (orange) interact with alkyne lyso-
phospholipid micelles (blue) in aqueous solution to form an emulsion.
Addition of the copper(I) catalyst (green) triggers the cycloaddition
reaction, which takes place primarily at the interface between the oil
droplets and the aqueous phase. Over time, the droplets are
consumed and replaced with vesicular phospholipid membrane
structures, both spherical and tubular. Bottom: reaction scheme of the
CuAAC, which is the key process for the formation of phospholipid
membranes.
7914 | Chem. Sci., 2017, 8, 7912–7922proceeds in aqueous medium with high specicity and a lack of
background reactions in the absence of a catalyst.
Follow-up work by Hardy et al. demonstrated that the CuAAC
reaction can be light-triggered by ruthenium tris-bipyridine
[Ru(bpy)3
2+] complex under mild aqueous conditions.23 The
ruthenium-copper electron transport chain was found to drive
the in situ formation of phospholipids in a high yielding
manner, which subsequently self-assemble into synthetic
membrane vesicles. Konetski et al. further demonstrated that
the incorporation of a photoinitiator complex into the CuAAC
reaction can be used to achieve spatiotemporal control over
vesicle assembly.24 It was also shown that the vesicle size and
morphology could be controlled by the intensity of light. We
foresee future applications of this simple photoinduced vesicle
formation technology in the controlled construction of complex
synthetic advanced cells.
In a separate work, Zhou et al. showed that a photo-initiated
thiol-yne click chemistry reaction could be used to rapidly
synthesize dithioether analogs of phospholipids in aqueous
solution.25 The resulting lipids were shown to possess physical
properties comparable to natural phospholipids. Their resis-
tance to phospholipases could potentially be useful for drug
delivery applications.2.3. Chemoselective ligation methodologies
Based on a similar strategy, Brea et al. utilized native chemical
ligation (NCL)26,27 to drive the chemoselective coupling between
a cysteine-functionalized lysophospholipid and a water-soluble
fatty acyl thioester (Fig. 3).28 This approach overcame some of
the drawbacks of the CuAAC-based approach. For example, it
did not require the use of any catalyst and both precursors were
water-soluble. Unlike the NCL reaction between peptide coun-
terparts, the reaction between the amphiphilic precursors was
found to be very rapid and high yielding. It went to completion
within 30 min with full conversion. This rate enhancement and
high efficiency can be attributed to the hydrophobic interaction
between the reactive partners, which brings them in close
proximity. The generated amidophospholipids were shown to
have physical properties like their natural counterparts. The
reaction was also shown to be compatible with biomolecules
and biologically relevant conditions.
Brea et al. further showed that histidine ligation (HL)29,30 can
be used in an analogous manner to de novo generate amide-
linked phospholipids (Fig. 3).31 In particular, the catalytic role
of the imidazole ring of a histidine-functionalized lysolipid was
utilized to drive its coupling to a fatty acyl thioester, which
affords a new class of amidophospholipids. The corresponding
phospholipids can spontaneously self-assemble into micron-
sized vesicles. Moreover, the selectivity, the high reaction rate
and the biocompatibility of this methodology are key features
that make it a powerful tool for the efficient encapsulation of
biomacromolecules, such as proteins. Remarkably, the HL
reaction, which was previously found to be quite inefficient for
peptide ligation, proceeded with high efficiency in an amphi-
philic milieu.This journal is © The Royal Society of Chemistry 2017
Fig. 3 Nonenzymatic and chemoselective approaches to spontaneously generate phospholipid membranes from water-soluble precursors.
Bottom: mechanisms for the native chemical ligation (NCL) and histidine ligation (HL) reactions.
Perspective Chemical Science
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View Article OnlineIn principle, any simple, robust, and chemoselective
coupling reaction that takes place under mild aqueous condi-
tion could be used to generate phospholipids in situ. This opens
up the opportunity to build a diverse toolbox for generating
lipid membranes chemically.Fig. 4 Dynamic vesicle formation based on covalent imine bonds.2.4. Reversible imine condensation
Over the last years, dynamic covalent chemistry (DCvC) has
been used to construct complex supramolecular assemblies
from discrete molecular building blocks using chemical reac-
tions carried out reversibly under conditions of equilibrium
control.32 An attractive strategy to create a dynamic vesicular
system is to exploit the reversible nature of imine condensa-
tion.33 In this particular case, an aldehyde and an amine can be
condensed to an imine at alkaline pH and the latter can be
hydrolyzed at acidic pH.33 The group of van Esch employed this
simple and elegant idea to demonstrate the de novo emergence
of vesicular structures, whose formation and disassembly can
be reversibly regulated simply by changing the pH (Fig. 4).34 The
introduction of dynamic covalent imine bonds represents a new
strategy for generating dynamic vesicular architectures, which
are highly interesting for controlled drug delivery because of
their easy formation, fast dissociation, and switchable
morphology. Using an analogous reversible imine–aldehyde
reaction, Takakura et al. were able to demonstrate the trans-
formation of submicroscopic micelles into GVs.35 In thisThis journal is © The Royal Society of Chemistry 2017particular example, it was shown that the hydrophobic envi-
ronment of micelles led to the release of a long-chain amine
from an imine. Subsequently, the long-chain amine reversibly
forms a new imine with a single-chain aldehyde to generate
a double-chained membrane-forming amphiphile.Chem. Sci., 2017, 8, 7912–7922 | 7915
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View Article OnlineMore recently, the Yi group used a similar approach to
develop a novel class of pH-responsive vesicular structures from
an equimolar mixture containing octyl amine and the supra-
amphiphiles 1-[10-(4-formyl-phenoxy) decyl] pyridinium (FDP)
or 1-methyl-3-[10-(4-formyl-phenoxy) decyl] imidazolium
(FDI).36 The efficient encapsulation of Nile Red and its rapid
release in a low pH environment demonstrated the capabilities
of these unilamellar vesicles to act as potential drug delivery
systems in a biological environment.3. Vesicle growth and division
promoted by catalytic membranes
Growth of vesicle membranes composed of single-chain
amphiphiles like fatty acids has been demonstrated simply by
addition of fresh monomers.37 However, owing to the less
dynamic nature of phospholipid membranes, in situ generation
of membrane-forming material is required for their growth.12
This can be accomplished either by a membrane-embedded
catalyst or by a soluble catalyst encapsulated within the
vesicle lumen. Also, there are examples where the hydrophobic
interior of the membrane itself has been shown to play a cata-
lytic role to drive a reaction. Generation of excess membrane
leads to an imbalance in the surface area to volume ratio, which
subsequently leads to budding and ssion events. This is
reminiscent of the division events which take place in L-form
bacteria.38
Over the last decade, the Sugawara group has investigated
this problem thoroughly. For instance, Takakura et al. reported
the self-reproduction of giant vesicles (GV) driven by an imine
hydrolysis reaction taking place in a membrane environment.39
Kurihara et al. also showed that the growth and division of giant
vesicles composed of various phospholipids and a cationic
amphiphile can be coupled with the polymerase chain reaction
(PCR) taking place inside the GVs (Fig. 5).40 In the rst step, PCR
led to the amplication of DNA encapsulated in the GVs. The
amplied DNA interacted with a cationic membraneFig. 5 Schematic representation of the amplification of DNA within
a self-reproducible giant vesicle (GV). Addition of membrane precur-
sors causes the growth and spontaneous division of the GVs, as well as
the efficient distribution of DNA to the daughter GVs.
7916 | Chem. Sci., 2017, 8, 7912–7922amphiphile to form a “pseudo-catalyst” complex which served
to facilitate the hydrolysis of a bolaamphiphilic membrane
precursor. Consequently, new membrane material was gener-
ated, thus leading to membrane growth and division. In
subsequent work, Kurihara et al. also showed that a model cell
cycle can be developed using a similar vesicular system.41
However, in all the previous examples, membrane growth led to
dilution of the catalyst and membrane formation could not be
sustained for more than a few rounds. Ideally, the reproduction
of the membrane should be coupled with the reproduction of
the catalytic species. This can be accomplished by an autocat-
alytic mechanism.
Simple autocatalytic reactions have been utilized in the past
to drive the growth of membrane-bound vesicles. Wick et al.
demonstrated the growth of oleic acid vesicles driven by the
autocatalytic hydrolysis of oleic anhydride droplets.42 Seeking
a catalytic strategy to obtain vesicle self-reproduction, Hardy
et al. recently reported the use of a self-replicating catalyst,43
which can continuously drive phospholipid formation by
CuAAC reaction over many generations in a high yielding
manner (Fig. 6).43 The catalytic species is a membrane-
embedded tris-(lauryl triazole) amine (TLTA)-Cu(I) complex,
which uses lauryl (dodecyl) azide for its own generation, as well
as for the generation of triazole-containing phospholipids.
Phospholipid formation led to growth of the membrane and
occasional division events. In principle, such a system should
be able to sustain efficient membrane reproduction if the
precursors are continuously replenished.
The current methods of articial vesicle growth and division
lack the sophistication or spatiotemporal control found in
living cells.37 However, we envision that these limitations can
potentially be overcome by coupling various strategies of de
novo membrane formation with nely tuned physicochemical
triggers or genetic circuits. Additionally, it would be desirable to
employ non-amphiphilic water-soluble precursors to rule out
non-specic interactions arising from incorporation of amphi-
philes into the membranes.
4. Remodeling artificial membranes
Biological membranes are highly dynamic structures.
Membranes can be remodeled in response to various stimuli by
altering the composition of the phospholipids. This results
from the transacylation activities of membrane-bound enzymes
in the presence of different lysolipid, phospholipid, and fatty
acid precursors.16 Several permutations of phospholipids can be
generated by this remodeling, which allows cells to modify
membrane properties. Therefore, the importance of this
process underscores the need for robust strategies to remodel
lipid composition in articial membranes. Researchers have
recently developed simplied membranes that mimic how
native phospholipid membranes are remodeled. For instance,
Brea et al. have shown that reversible chemoselective reactions
can be harnessed to achieve nonenzymatic spontaneous
exchange and remodeling of both lipid tails and head groups in
synthetic membranes.44 Using this approach, they demon-
strated the ability of phospholipid remodeling to triggerThis journal is © The Royal Society of Chemistry 2017
Fig. 6 Self-reproducing system that can drive the repeated synthesis and growth of phospholipid membranes by using a CuAAC reaction. The
regeneration of membrane-bound autocatalysts continually induces the formation of triazole phospholipids, mimicking natural membrane
generation.
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View Article Onlinechanges in vesicle spatial organization, composition, and
morphology, as well as the recruitment of proteins that can
affect membrane curvature. The feasibility of remodeling
phospholipid membranes was initially demonstrated by using
reversible transthioesterication/acyl shi reactions for the
construction of dynamic membranes that modulate their
physical and chemical properties through efficient exchange of
their phospholipid tails. Remarkably, in situ membrane
remodeling by lipid tail exchange also lead to subsequent
micrometer scale changes in membrane morphology and the
formation of distinct lipid microdomains (Fig. 7).Fig. 7 Lipid microdomain formation induced by in situ nonenzymatic
remodeling of phospholipid membrane architecture. GUVs composed
of unsaturated phospholipids are remodeled by lipid tail exchange
reactions with a saturated cysteine-modified lysophospholipid, leading
to the formation of a new class of GUVs composed of a mixture of
unsaturated and saturated lipids. After addition of the corresponding
lysophospholipid, membrane remodeling rapidly takes place and
subsequent microdomain formation is observed, as indicated by the
partitioning of Texas Red® DHPE dye into discrete circular regions of
the membrane.
This journal is © The Royal Society of Chemistry 2017In addition to controlling membrane uidity, Brea et al. were
able to modulate the membrane association of amphiphysin45,46
and epsin 1 47 by using a lysophospholipid possessing a nega-
tively charged head group.44 Amphiphysin and epsin 1 are
proteins that bind to negative phospholipid membranes and
induce positive curvature of the surface.45–47 Aer in situ
remodeling of membranes, the corresponding protein was
added, and dramatic curvature events in the negatively charged
vesicles were observed.
We foresee future applications of the in situ lipid remodeling
approach for studying the specic effects of lipid fragment
exchange in minimal model membranes. An interesting appli-
cation would be devising an articial approach to the recon-
stitution of whole lipid ras.5. Reconstruction of lipid-
synthesizing machinery in vesicles
Linking gene expression with phospholipid membrane forma-
tion is one of the highly sought aer goals of bottom-up
synthetic biology.48 The ability to form phospholipids by an
enzyme-catalyzed reaction provides control over membrane
assembly on a genetic level. Over the last few decades, there has
been signicant interest and effort for developing robust strat-
egies to drive lipid membrane synthesis from well-dened
enzymatic systems. Most of the work to date has been focused
on reconstitution of the de novo (Kennedy) pathway of phos-
pholipid synthesis.49 In this pathway, phospholipid synthesis
takes place by adding various substituents to glycerol-3-
phosphate (G3P) in several enzyme-catalyzed steps.Chem. Sci., 2017, 8, 7912–7922 | 7917
Fig. 8 Construction of membrane proteins in minimal synthetic cells.
(A) Schematic representation of a lipid-synthesizing liposome. The key
membrane proteins (GPAAT and LPAAT) are expressed by using an
encapsulated cell-free system (PURE system) in the presence of
appropriate reactive precursors [TX–TL: transcription/translation]. (B)
G3P is initially converted into LPA by using the protein GPAAT. Then,
the resulting LPA is used as a substrate to catalyze the formation of PA
using the protein LPAAT.
Chemical Science Perspective
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View Article OnlineThe Luisi group has produced extensive work in this area. In
the rst example, Schmidli et al. showed that phosphatidylcho-
line synthesis can be effected by using four puried membrane
proteins bound to a liposome membrane.50 In a later work,
Kuruma et al. demonstrated that vesicles encapsulating a cell-
free transcription/translation (TX-TL) system (PURE® system)
can express two membrane proteins (GPAAT and LPAAT), that
can catalyze the formation of new phosphatidic acid (Fig. 8).51
Very recently, the Danelon group demonstrated that a total
of eight E. coli enzymes for various acyl transfer and head group
modication reactions can be expressed in the PURE® system
and reconstituted in liposomes.52 A different approach was
taken by Murtas, where he reported vesicle growth arising from
internal fatty acid synthesis catalyzed by a single soluble
bacterial enzyme complex FAS-B (type I).53
However, these approaches were met with low overall yields
(<10%), thus limiting their scope of application towards vesicle
growth and division.48 Also, de novo membrane formation was
not demonstrated as the biosynthetic enzymes require pre-
existing membranes to be functional. A major challenge to
the encapsulation of the natural lipid synthesis machinery is
the difficulty of reconstituting the various membrane-bound
proteins involved in phospholipid biosynthesis. Continued
supply of precursors and cofactors can be also challenging if
they are charged and membrane impermeable. This difficulty
can be partly alleviated by introduction of pore forming proteins
to the membranes. We also believe that approaches radically
different from the natural pathways can also be useful to
approach to this problem. Linking enzymatic reactions with the
coupling strategies discussed in the previous sections could
help minimize the number of components used for lipid
synthesis and possibly improve the efficiency.Fig. 9 Membrane localization of proteins by SNAP-tag reaction with
lipid-anchored substrates. (A) Schematic representation of the reac-
tion between a SNAP-tag protein and a benzylguanine (BG)-func-
tionalized phospholipid membrane. (B) Fluorescence microscope
image showing spatiotemporally controlled membrane localization of
an Alexa Fluor® 488 labeled SNAP-tag protein on a GUV.6. Functionalization of artificial
membranes
For the bottom-up construction of an articial cell, a major goal
will be the functionalization of the membranes with suitable7918 | Chem. Sci., 2017, 8, 7912–7922proteins. In this section, we will discuss various methods of
specic localization of both soluble proteins and integral
membrane proteins to articial membranes.6.1. Mimicking membrane-anchored proteins
In living cells, recruitment of soluble proteins to membranes is
an important event in cellular signaling, cell recognition, and
for affecting membrane curvature.54 This is accomplished by
attaching the protein to a site-specic lipid anchor (e.g. palmi-
toylation, prenylation)55 or to a phospholipid head group [e.g.
glycerophosphoinositol (GPI) anchor].56 Therefore, it would be
interesting in synthetic biology to develop analogous tools for
site-specic localization of proteins to articial membranes.
Rudd et al. described a methodology of covalent protein local-
ization to giant unilamellar vesicle (GUV) membranes based on
the chemoselective reaction between benzylguanine (BG)-
functionalized phospholipid anchors and a SNAP-tagged GFP
(Fig. 9A).57 It was also shown that the process could be spatio-
temporally controlled using light with high precision (Fig. 9B).
Over the last years, van Hest group has been developing
efficient strategies for controlling the recruitment of proteins to
membranes. For instance, Peters et al. have recently exploited
the non-covalent interaction between a Ni-NTA modied lipid
and an oligo-His tagged protein for the latter's localization to
GUV membranes.58 Exploiting the pH-dependent nature of this
interaction, it was also shown that the binding could be
reversibly switched by coupling the process with the enzymatic
activity of alcohol dehydrogenase.6.2. Reconstitution of transmembrane proteins
Reconstitution of membrane proteins is particularly interesting
because of their diverse roles in signal transduction, transport,
ligand binding, membrane architecture, and cellular adhe-
sion.54,59,60 However, it is a challenging task to reconstitute integral
membrane proteins in their functional form because of the poor
aqueous solubility of their transmembrane domains.61 Conven-
tional methods involve detergent solubilization, organic extraction
or mechanical fragmentation followed by transfer to a liposome.62
Although several membrane proteins have been reconstitutedThis journal is © The Royal Society of Chemistry 2017
Fig. 11 Incorporation of A2AR into synthetic liposomes. (A) Schematic
representation of the NCL-based phospholipid membrane formation
with embedded A2AR. (B) [
3H]-ZM241385 saturation curves with
INSYRT reconstituted A2AR proteoliposomes (blue line) and A2AR–HDL
reconstituted nanodiscs (orange line). Radiolabeling experiments
showed that both methodologies are similar based on their observed
Kd and Ki.
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View Article Onlineusing this technology, the process is very time consuming and
residual detergents adhering to the liposomes can inuence the
protein's properties as well as subsequent analyses.63
Cole and co-workers tackled this problem by coupling bio-
orthogonal methods of in situ phospholipid membrane formation
to spontaneous membrane protein reconstitution (Fig. 10).64 In
this strategy, a functionalized (e.g. terminal alkyne or cysteine)
lysophospholipid was imparted a dual role. In the rst step, the
lysolipid functioned as a detergent in solubilizing the protein in
micelles. In the next step, the lysolipid reacted with a suitable
partner (e.g. alkyl azide or fatty acyl thioester) in a bioorthogonal
manner to generate a phospholipid which assembled to form
membranes along with spontaneous reconstitution of the protein.
CuAAC reaction was utilized to reconstitute commercially avail-
able cytochrome c oxidase (CcO)65,66 – a transmembrane protein
universally important in aerobic respiration.67 The protein could
be reconstituted in functional form with efficiency comparable to
more traditional methods. Next, the same reaction was utilized to
reconstitute MsbA68–70 – an ABC transporter protein from bacterial
cell lysate – into in situ formed liposomal membranes. Lastly, NCL
reaction was used to accomplish the reconstitution of a mamma-
lian plasma membrane calcium ATPase fusion protein called
PMCA2-EGFP71 in functional form. This task was particularly
challenging because the protein has ten transmembrane domains
and can only be expressed in mammalian cells with low yields.72
Use of the NCL approach proved to be advantageous over the
CuAAC methodology in this particular case because traces of
imidazole le over from protein purication inhibited CuAAC but
had no signicant effect on NCL.
Brea and co-workers more recently showed that the scope of
the NCL-based method could be expanded to incorporate
adenosine A2A receptor (A2AR) – a G-Protein Coupled Receptor
(GPCR)73,74 – into synthetic membranes formed in situ (Fig. 10
and 11).75 It is noteworthy that GPCRs constitute the largest
class of eukaryotic transmembrane receptor proteins and their
study is important for understanding the mechanism of actionFig. 10 Model for spontaneous reconstitution of transmembrane
proteins during in situ phospholipid membrane formation. The desired
protein is initially solubilized with a synthetic mimic of a detergent to
form micelle-solubilized protein complexes. Addition of the comple-
mentary reactive precursor and subsequent coupling results in the
spontaneous generation of the corresponding proteoliposomes [CcO:
cytochrome c oxidase, PMCA: plasma membrane calcium ATPase,
A2AR: adenosine A2AR receptor].
This journal is © The Royal Society of Chemistry 2017of many small biomolecules, hormones, and drugs.76,77
However, current methodologies for their functional reconsti-
tution in biomimetic membranes remains both challenging
and limited in scope.78 The NCL-based strategy proceeds in the
absence of dialysis and/or detergent absorbents, which make it
a powerful tool for the assimilation of GPCRs into synthetic
liposomes. This methodology, dubbed as INSYRT (In situ lipid
synthesis for protein reconstitution technology), uses a thio-
ester analog of the commonly used non-ionic detergent n-
dodecyl-b-D-maltoside (DDM).79 Similar to the previous strate-
gies, the DDM thioester plays the dual role of protein solubi-
lizing detergent and phospholipid precursor. The micelle-
solubilized A2AR is treated with equimolar amount of the
cysteine-functionalized lysolipid to form the corresponding
phospholipid by NCL, which subsequently leads to stable lipo-
some generation and concurrent embedding of A2AR in the
membrane. INSYRT proceeds in approximately 20 min without
the need for additional post workups or purications. The
reconstituted GPCR was shown to be capable of interacting with
known orthosteric ligands, such as the antagonist [3H]-
ZM241385 (Fig. 11B). Additionally, radiolabeling experiments
showed that the reconstitution of A2AR during INSYRT yielded
similar ligand-binding results when compared to the traditional
high-density lipoprotein (HDL)80 based reconstitution method
as evident from the observed dissociation constant (Kd) and
inhibitory constant (Ki) (Fig. 11). The INSYRT methodology
could be employed as a powerful general tool for the structural
and functional study of membrane proteins.7. Conclusions and future directions
The pursuit of developing synthetic cells from the bottom-up
could be rewarding in several ways. First, it may help usChem. Sci., 2017, 8, 7912–7922 | 7919
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View Article Onlineanswer some of the most fundamental questions pertaining to
the very denition of life. For instance, what is the minimum
biochemical requirement for life or what were the key steps
leading to the origin of life on Earth and possibly elsewhere. In
this perspective, we discussed that model systems based on
simple coupling reactions between amphiphilic precursors can
provide us hints at how complexity arose in early protocell
membranes. However, it is still not clear how such activated
amphiphiles might have been generated under prebiotic
conditions. It has been suggested that ribozymes had once
occupied the biochemical niche of fatty acid activating enzymes
and acyltransferases;6 but no such ribozyme has been discov-
ered so far. So, it stands as an exciting challenge to develop
facile routes for fatty acid activation using a macromolecular
catalyst (e.g. ribozymes or enzymes). Such efforts will help
bridging important gaps in the understanding of the evolution
of membrane synthesis machinery. Furthermore, such
biochemical functionalities can be incorporated into genetic
circuits to trigger membrane synthesis and growth in response
to a stimulus. In the grand scheme of construction of synthetic
life, it is highly desirable to develop a system capable of
undergoing Darwinian evolution. It has been shown that simple
physical effects can lead to the origin of competition among
model protocells.2 Also in a separate work, it was shown that
spontaneous mutations can be acquired in simple genomic
systems over multiple generations in an articial cell-like
compartment.81 In the future, it will be highly interesting to
combine the above two concepts and develop a vesicular proto-
cellular system capable of Darwinian evolution through
a combination of acquired genetic mutations and benecial
physical traits. Secondly, articial cells could serve as model
systems for the study of complex biochemical processes. For
example, reconstitution of membrane proteins in articial
membranes could be useful for deepening our understanding
of how ligands and drugs interact with various receptors in
a signaling pathway. Thirdly, we envision that strategies of de
novo membrane formation can potentially be applied to novel
applications in living cells. Lipids remain among the less
understood and explored classes of biomolecules. There are
multiple disease conditions where aberrations in membrane
uidity, lipid metabolism and signaling pathways are impli-
cated.82–84 It will be particularly interesting to explore if site-
specic or stimuli-responsive lipid synthesis and/or remodel-
ing in cells can ameliorate such conditions. Finally, bottom-up
construction of life-like materials will potentially open new
avenues for applications in therapeutics, drug delivery,
biosensors, and biofuels. Articial cells could possibly be
utilized as smart delivery vehicles for precise spatiotemporal
control in targeting and release of the pharmaceutical payloads
in disease cells. Moreover, articial cells could be utilized for
rapid and clean synthesis of environmentally friendly fuels.
Therefore, the possibilities are endless and will pose exciting
challenges to scientists across many disciplines in the future.
We believe that various methods of de novo vesicle formation
will be useful as tools for understanding how membranes can
be assembled from basic building blocks and similar ideas
could be implemented for studying other self-assembly7920 | Chem. Sci., 2017, 8, 7912–7922processes. These strategies serve to demonstrate how
synthetic pathways – parallel or even radically different from
their biological counterparts – could be incorporated in the
approach to bottom-up construction of an articial cell.
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